There is considerable evidence that the mucosa associated lymphoid tissues (MALT) of the body play an active part in triggering off and conducting the immune system's response to both viral and bacterial pathogens. Effectors are capable of intercepting the micro-organisms and rendering them harmless before they penetrate through the mucous membranes, or of expelling and inactivating them after they have penetrated. The system is consequently useful both in the prevention of infection and in the humoral or cellulo-mediated immune response. These operations, whose principal protagonists are Immunoglobulins A and dendritic cells, are made possible by the high degree of functional interconnection which binds the effectors of the system and the anatomical structures located in the mucosae. The data provided in literature consequently infer that appropriate stimulation of mucosal immunity, which takes into account the new acquisitions in the field of immunology, can enable oral vaccination to overcome the obstacles encountered up till now in terms of insufficient protection against diseases.
MowatA.M.VineyJ.L.1997. The basis of intestinal immunity. Immunol. Rev.156:145.
2.
MatsunagaT.RahmanA.2001. In search of the origin of the thymus and GALT may be evolutionarily related. Scand. J. Immunol53:1.
3.
OlofssonK.HellstromS.HammarstromM.L.1998. The surface epiteliumof recurrent infected palatine tonsils in rich in gd T cells. Clin. Exp. Immunol.111:36.
4.
el-SebaiM.M.el-HelalyS.M.AlyA.G.FarisL.1991. Correlation between the level of IgA and pneumocystis Carinii infection. J. Egypt. Soc. Parasitol.21:771.
GleesonM.HallS.T.McDonaldW.A.FlanaganA.J.ClancyR.L.1999. Salivary IgA subclasses and infection risk in elite swimmers. Immunol. Cell Biol.77:351.
7.
ChaushuS.YefenofE.BeckerA.ShapiraJ.ChaushuG.2002. A link between parotids salivary Ig level and recurrent respiratory infections in young Down's syndrome patients. Oral Microbiol. Immunol.17:172.
8.
GleesonM.CrippsA.W.ClancyR.1995. Modifiers of the human mucosal immune system. Immunol. Cell Biology73:397.
9.
McWilliamA.S.NelsonD.ThomasJ.A.HoltP.G.1994. Rapid Dentritic Cell recruitment is a hallmark of the acute respiratory response at mucosal surfaces. J. Exp. Med.179:1331.
10.
BernsteinJ.M.ReddyM.S.ScannapiecoF.A.FadenH.S.BallovvM.1997. The microbial ecology and immunology of the adenoid: Implications for otitis media. Ann. NY Acad. Sci.830:19.
11.
KaulD.OgraP.L.1998. Mucosal responses to parenteral and mucosal vaccines. Dev. Biol. Stand.95:141.
12.
LewisD.J.HaywhardC.M.2003. Stimulation of mucosal immunity. Methods Mol. Med.87:245.
13.
NeutraM.R.FreyA.KraehenbuhlJ.P.1996. Epithelial cells: Gateways for mucosal infection and immunization. Cell86:345.
14.
LambrechtB.N.PrinsJ.B.HoogstedenH.C.2001. Lung dedritic cells and host immunity to infection. Eur. Respir. J.18:692.
15.
UnderdownB.J.MesteckyJ.1994. Mucosal immunoglobulins. In Handbook of mucosal immunology. OgraP.MestecekJ.LammM.E.StroberW.McGheeJ.R.BienenstockJ., ed. Academic Press. Boston, p. 79.
16.
KanteleA.WesterholmM.KanteleJ.M.MakelaP.H.SavilahtiE.1999. Homing potentials of circulating antibody-secreting cells after administration of oral or parenteral protein or polysaccharide vaccine in human. Vaccine17:229.
17.
Bokor-BraticM.2000. Clinical significance of analysis of immunoglobulin A levels in saliva. Med. Pregl.53:164.
18.
BrandtzaegP.1994. Distribution and characteristics of mucosal immunoglobulin-producing cells. In Handbook of mucosal immunology. OgraP.MestecekJ.LammM.E.StroberW.McGheeJ.R.BienenstockJ., ed. Academic Press. Boston, p. 251.
19.
BrandtzaegP.FarstadI.N.JohansenF.E.MortonH.C.NorderhaugI.N.YamanakaT.1999. The B-cell system of human mucosae and exocrine glands. Immunol. Rev.171:45.
20.
MazanecM.B.NedrudJ.G.KaetzelC.S.LammM.E.1993. A three tired view of the role of IgA in mucosale defence. Immunol. Today14:430.
21.
LammM.E.NedrudJ.D.KaetzelC.S.MazanecM.B.1995. IgA and mucosal defence. APMIS103(4):241.
22.
MelioliG.2003. The immunoresponse aganist bacterial antigens is generated in vivo by a mechanical lysate through a cross-talk between innate and adaptative immunity. ERS Annual Congress, p. 1
23.
VojdaniA.KashanianA.VojdaniE.CampbellA.W.2003. Saliva secretory IgA antibodies against molds and mycotoxins in patients exposed to toxigenic fungi. Immunopharmacol. Immunotoxicol.25:595.
24.
BrandzaegP.2003. Role of secretory antibodies in defence agains infections. Int. J. Med Microbiol.293:3.
25.
HarabuchiY.FadenH.YamanakaN.DuffyL.WolfJ.KrystofikD.1994. Human milk secretory IgA antibody to nontypable H. Influenzae: Possible protective effect against nasopharyngeal colonization. J. Pediatr.124:193.
26.
DevitoC.BrolidenK.KaulR.SvenssonL.JohansenK.KiamaP.KimaniJ.LopalcoL.PiconiS.BwayoJ.J.PlummerF.ClericiM.HinkulaJ.2000. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. J. Immunol.165:5170.
27.
HeystekH.C.MoulonC.WoltmanA.M.GaronneP.van KootenC.2002. Human immature dendritic cells efficiently bind and take up secretory IgA without the induction of maturation. J. Immunol.168:102.
28.
CrippsAWKydJMFoxwellA.R.2001. Vaccines and mucosal immunization. Vaccine19:2513.
MoldoveanuZ.RusselM.W.WuH.I.HuangW.Q.CompansW.MesteckiJ.1995. Compartimentalization within the common mucosal immune system. Adv. Exp. Med. Biol.371:97.
31.
OienN.L.BrideauR.J.WalshE.E.WathenM.W.1994. Induction of local and systemic immunity against respiratory syncytial virus using chimeric FG glycoprotein and cholera toxin B-subunit. Vaccine12:731.
32.
OrozcoA.R. Rodriguez2003. The difficulty of obtain immunologic response in mucosae. Use of coadjuvants. Rev. Alerg. Mex.50:161.
33.
Maldonado-LopezR.MoserM.2001. Dendritic cell subsets and the regulation of Th1/Th2 responses. Semin. Immunol.13:275.
34.
UyemuraK.CastleS.C.MakinodanT.2002. The frail elderly: Role of dendritic cells in the susceptibility of infection. Mech. Aging Dev.123:955.
